Founded in Eugene, Oregon in 2011, NemaMetrix Inc. specializes in developing and manufacturing devices, consumables, and software for worm screening and phenotyping.
The company’s mission is to enable scientists and researchers around the world to better understand human diseases and explore potential treatments for high-impact disorders such as Alzheimer’s disease, and ALS (Lou Gehrig’s Disease), and cardiac arrhythmias by offering a more affordable and rapid system that supplements the traditional mouse model.
Our ScreenChip System, a first-in-class automatic screening and phenotyping platform utilizing C. elegans as the model organism, which acquires and displays neuromuscular data in real time. The technology allows researchers to rapidly generate and collect precise whole-animal data via quick and reliable assessment of neuronal and physiological responses to genetic mutations, drug effects and other environmental changes. The platform provides an alternative to enable researchers to better understand human diseases and explore potential treatments for high-impact disorders.
Our customers are currently using the ScreenChip technology as a platform for investigations into aging, neurodegenerative diseases, arrhythmia cardiac diseases, developmental biology and environmental toxicology.